Meeting
2018 ASCO Annual Meeting
Various checkpoint proteins, and tumor infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy.
Authors
Kazuhiro Mochizuki
Fukushima Medical University, Fukushima, Japan
Kazuhiro Mochizuki , Satoshi Kawana , Moe Muramatsu , Hideki Sano , Shogo Kobayashi , Yoshihiro Ohara , Nobuhisa Takahashi , Yuko Hashimoto , Atsushi Kikuta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10544)
DOI
10.1200/JCO.2018.36.15_suppl.10544
Abstract #
10544
Poster Bd #
217
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Activation of CD8+ tumor infiltrating lymphocytes by bavituximab in a 3D ex vivo system of lung cancer patients.
First Author: Soner Altiok
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.
First Author: Jose Antonio Lopez Guerrero
Poster
2018 ASCO Annual Meeting
Immune profiling in a randomized phase II trial of acalabrutinib and pembrolizumab (PA) versus pembrolizumab (P) for patients with metastatic urothelial cancer (mUC).
First Author: Tian Zhang
Poster
2016 ASCO Annual Meeting
Molecular characterization of immune exclusion in small-cell lung cancer.
First Author: Sope Omowale Olugbile